The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative impact of treatment on clinical benefit in patients with glioblastoma (GBM) enrolled in the phase II trial of ICT-107.
 
Terri S. Armstrong
Consulting or Advisory Role - Tocagen
Research Funding - Merck/Schering Plough
 
Patrick Y. Wen
No Relationships to Disclose
 
David A. Reardon
No Relationships to Disclose
 
Surasak Phuphanich
No Relationships to Disclose
 
Robert Aiken
Honoraria - Novocure
Travel, Accommodations, Expenses - Novocure
 
Joseph C. Landolfi
Honoraria - Genentech; Novocure
Consulting or Advisory Role - Genentech; Novocure
Travel, Accommodations, Expenses - Genentech; Novocure
 
William T. Curry
Consulting or Advisory Role - Stryker
 
Jay-Jiguang Zhu
Consulting or Advisory Role - Novocure
Research Funding - Dekk-Tec; Diffusion Pharmaceuticals; ImmunoCellular Therapeutics; Novocure
 
Michael J. Glantz
Honoraria - Sigma-Tau
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Sigma-Tau
 
David M. Peereboom
Honoraria - Genentech; Merck KGaA
Consulting or Advisory Role - Novocure
Research Funding - Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
James Markert
Employment - Laili Radpour-Markert (I)
Stock and Other Ownership Interests - Aettis; Catherex
Consulting or Advisory Role - Catherex
Research Funding - ImmunoCellular Therapeutics; Oncolytics; Sun Bio IT Solutions
Patents, Royalties, Other Intellectual Property - Aettis
 
Renato V. LaRocca
Stock and Other Ownership Interests - UbiVac
Consulting or Advisory Role - Arbor Pharmaceuticals; Celgene; Novocure
Speakers' Bureau - Celgene
Patents, Royalties, Other Intellectual Property - NIH 50B, 522
 
Donald O'Rourke
Research Funding - Celldex
 
Karen L. Fink
Honoraria - Genentech; UCB
Consulting or Advisory Role - Novocure
Speakers' Bureau - Genentech; UCB
Research Funding - Celldex (Inst); Diffusion Pharmaceuticals (Inst); Genentech/Roche (Inst); ImmunoCellular Therapeutics (Inst); Lilly (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst)
 
Lyndon J. Kim
No Relationships to Disclose
 
Michael L. Gruber
No Relationships to Disclose
 
Glenn Jay Lesser
Honoraria - Merck (I)
Consulting or Advisory Role - Abbvie; Stemline Therapeutics
Research Funding - Celldex; ImmunoCellular Therapeutics; Northwest Biotherapeutics
 
Edward Pan
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Genentech; Novocure
Speakers' Bureau - Sigma-Tau
 
Santosh Kesari
Research Funding - Clinical Trial (Inst)
 
John Yu
Employment - ImmunoCellular Therapeutics
Leadership - ImmunoCellular Therapeutics
Stock and Other Ownership Interests - ImmunoCellular Therapeutics
Patents, Royalties, Other Intellectual Property - ImmunoCellular Therapeutics